Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Medical Officer
-
Issuer Symbol
-
KALV on Nasdaq
Paul K. Audhya - trading volume in the past year for KalVista Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
138,983 |
$2,163,520 |
$15.57 |
23 Feb 2026 |
Direct |
|
|
| Restricted Stock Units |
100,000 |
$1,002,000 |
$10.02 |
21 Feb 2025 |
Direct |
Common Stock |
|
| Restricted Stock Unit |
45,000 |
$651,300 |
$10.02 |
22 Feb 2026 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.